chartexchange

vTv Therapeutics Reports Q3 2026: $11.6 Million Net Loss and $36. ...

GuruFocus | Nov 5, 2026 5:32 PM EST

Cash of $77.2 Million Expected to Fund Operations Through Mid-2027 CATT1 Topline Readout Related Stocks: VTVT ,

Read original article